comparemela.com

Latest Breaking News On - Ysios capital - Page 8 : comparemela.com

Adcendo ApS Announces Option License Agreement with Duality Biologics to Enhance Optionality to Further Expand First-in-Class ADC Pipeline

/PRNewswire/ Adcendo ApS ("Adcendo"), a biotech company focused on the development of breakthrough antibody-drug conjugates (ADCs) for the treatment of.

VarmX raises funds to obtain IND approval for VMX-C001

Biotechnology company VarmX has raised an additional €30m in a Series B2 financing round to obtain IND approval for its lead compound VMX-C001.

VarmX Raises €30 Million Series B2 Financing for IND Approval and Preparations for Pivotal Trial

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.